Mascot

MASCOT, Australia, March 15, 2010 - Boston Scientific Corporation (NYSE: BSX) announces that it received Australian Therapeutic Goods Administration (TGA) approval for its PROMUS(R) Element(TM) and TAXUS(R) Element(TM) Stent Systems, the Company's third-generation drug-eluting stent (DES) technology.